Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 341–350 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 341

    Medicine slug
    cyclobenzaprine
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    190
    Source count
    165
    Agreement rate
    1
    Recorded readings

    1. 33%

      Numeric value
      33
      Unit
      %
      Source records
      165

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 165 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4dcbdf8f-37ce-0f90-e063-6394a90ae83c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390151d4-5fcb-46e2-92e6-de184827f43d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ebaccfc-f57c-4547-ade0-6a6e204f5ea0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74af1727-e84f-4dad-82be-045e7d23beaf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db930d05-3f92-41f1-888c-301b2c4565e6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e505c31b-4618-4e4f-8da6-92030464004f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c054230-1978-44d2-9467-ed1994619113 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81917fa4-c79c-46e2-bfbb-507fc0d7ed1b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a397e88-d267-feed-e063-6294a90a7710 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f558863b-ea3f-4e4b-85e9-edb2573e7151 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d9e34cc-eee9-4147-abf8-c810a80e39d2 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51d85ea8-8317-4a76-a108-20383f118ad4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c3a3b4f-7b2b-3fe9-e063-6394a90aae47 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ac77323-7526-a129-e063-6394a90a641b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afca2a49-6424-7b6a-e053-2a95a90ad41e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1cb40f47-7fbb-4537-922d-04a08dd921c5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f32bceda-1d24-322d-e053-2995a90aae1b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:348c7ad4-b380-4b78-88f4-106b94079f52 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eb2b24b1-2851-440f-9075-b6a123a1fd5c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e6d82b-52fd-cca3-e063-6294a90a1104 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34e57aff-dc4b-4631-9d57-31020244835d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5023b8a5-c9df-84a4-e063-6294a90a9606 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a3a13c3-116c-4e9e-a7f3-7ad7c80486c3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4ae481f-9e47-470a-b4d1-5a33c0df8761 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:592871f6-0eb2-4624-9e10-bd8bf767c002 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07e3ec53-f1f2-4231-aec6-1772a146ba88 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e332763b-00c6-41bf-84ae-a07d9ef79697 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db49801d-9bde-5dd0-e053-2a95a90aee53 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30ca08c7-4ee3-2f37-e063-6294a90ae31a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f1b9c8a-8f75-4b84-af0c-739815937fd7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41838966-de0b-4855-83b8-2ff6c764ed1f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bddfe25-00ba-747f-e063-6394a90a9ce6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f89c8f6-7f3c-8396-e063-6294a90a643e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53688de9-2031-4d19-b422-4000285f7f47 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:08adc97f-feef-46fb-ac75-f015b4f3a43a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf5d4de9-79c3-4935-be69-89e98d7b54cc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a90171b-aef3-0691-e063-6294a90a6560 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3b5fc92-9186-6944-e053-2a95a90a1c9f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:794d350b-6c88-41d5-b68b-3e2c57ee2a4f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c86303a0-7c8b-415e-acac-1070b7d0d445 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8bdc725e-22e3-0f32-e053-2a95a90ae8a9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f321a03-ccfb-4c11-ac60-a461a5580c69 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa29e260-fb77-415a-a505-3230d30c8945 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3baeda95-d098-437a-b360-87a9c3f3fd9b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf3c4c2e-b089-4f83-9c6a-7ca9d9abd3ba (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:269bc278-963d-4830-816a-39bb4bf8c936 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3187074-6b55-44a3-b969-40a808eb034a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f708cf0f-8373-14a2-e053-6394a90ab3fe (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b834bd5-9ee6-42a4-819c-5c605fd18e1f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ee4feec-4590-fa7f-e063-6394a90a5550 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b09ca979-ab6b-441b-a66f-41ca32eae6cb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53bef1ab-55c0-cc52-e063-6394a90a12b3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43ce2c79-ec4a-5120-e063-6394a90af6e1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d6448bb1-9b8d-45f4-a14b-8328248e586e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dcef9b63-f998-4852-920d-c356623cea6a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae6de8d8-33c2-40bd-9dd3-782c879a9d8f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f14bc532-e30f-490f-b97b-d0dab9a2ba0c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3998083-e3db-4052-9b5b-19d7aaa4e658 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88bdee56-d6d9-4f14-be77-1e6898ba36f5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a6b2ad9-307a-4976-98b7-1b96e0408da7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a2d3cae-5c64-4986-9707-cc213b70b7ad (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59f31ca3-1b28-4768-bb29-520f06f4a9f5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7829a96a-3668-4d88-90e9-0ecbedb2bd7e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37c8c0d6-98c0-c1a5-e063-6394a90a7931 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6536b470-9a4e-4174-85b8-479f64cc3296 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc93038f-1202-47f3-a959-2877877cc869 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbe6ba88-0581-50ef-e053-6394a90ab086 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4e0f532-887b-40bb-80d6-5c4e5b1d64bf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06da53af-5b46-4e32-a64c-9677e27ae229 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf81da00-7c6d-4477-bb70-b3c2abea177a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e4e8bab3-c5e7-4d2b-9692-ee6c6799b120 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8bef97d4-1b92-4316-8733-7751d627230f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:571fbb2b-24e0-4de3-8cfa-c267fc397b6c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1adcdd8a-30f9-4a7b-853c-948a5589acab (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afca1267-4d8f-7453-e053-2995a90a865c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a58cf759-048b-6740-e053-2a95a90a8b43 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc61c9f5-b0ec-3ff8-e053-6394a90adeb7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bb92f6-ec8c-4636-8b07-8814417fe78e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34f4e63a-1259-0226-e063-6294a90a9fc4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64f6d1be-4067-a5c7-2343-4aed651a0cac (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dae3be94-a40c-5be1-e053-2a95a90a1484 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac8ae965-af50-41d3-8df5-ca6daf4bbd1c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae3a3f5c-fb64-4a43-be88-a2fc7c298ac1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:820dca15-5b7f-41e0-955f-73f942709264 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:508e310e-067a-4f95-869a-e1da49aabe94 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16ed7d7e-862f-db36-e063-6394a90a02a5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:106d9730-5938-8f27-e063-6294a90adc68 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2eb32c3-3da0-4938-9ed9-ea8420450fde (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afcab35f-4ab9-33a4-e053-2a95a90ad529 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b524d150-0a83-42d1-a884-b930e49760cd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85128989-bfa3-4b82-94c1-f90b14ccd2f9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:68db3c3b-8da1-4852-90b0-3172f842aa02 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be5201bc-e1f1-41af-be46-4a8fbb223b86 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:01e18825-1cf9-a98c-e063-6294a90ae0a4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:418e3974-f7dd-4f27-bee5-3c2fb0531c4c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbd38abb-02ae-1a36-e053-6294a90abe65 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05641925-7b10-4b30-b6e8-44b416a5e77e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96207b29-033b-46a3-961f-e5125288d50f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9161cb5e-63e5-41d7-9bde-66c7b7b7a2f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4383b26f-c39f-3d6a-e063-6294a90aba03 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4eaa675a-c24c-4043-8fdf-9d59e5e4f4d5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a2b5f25-a333-15f3-e054-00144ff8d46c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe81c68d-a579-4fe9-e053-6294a90a7bc0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55683c5c-0f86-9a26-e063-6294a90a8e8c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df902d94-9d2b-4139-aebb-3eb6b8b8cd54 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0280b504-4a42-44f3-8a1a-34a20eac054a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8dec4e2-3151-4a79-b194-a11a57ada0b6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:014dd648-5b84-4d1d-80fc-a467e2d741ef (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15aad4af-5c05-be36-e063-6294a90a9bb3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4923ac1f-d463-465b-9e99-7312aef87861 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ceb56ab8-4a76-6dee-e053-2995a90aab30 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1154688c-1383-442b-a3a5-ec01e038795c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:751f0d33-ceff-40b0-9329-9125f176e06a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c66b5ed-f773-0779-e053-2995a90ad1f1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:193744c8-ff8e-4f65-aec1-1c13f471ac82 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a695685-cfec-464e-840c-32e3b7a68bd3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afcad582-ab59-4f70-e053-2a95a90a04e4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b062cb80-79a9-c5d8-e053-2a95a90aecfc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59b428fa-5013-4b2b-872f-16ba4a9d4f5d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a264ab9f-cc12-325f-e053-2a95a90a53d9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eb908b77-741c-473a-b2e9-4f82167c3088 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:47d22c6d-49fb-f97c-e063-6294a90a6ba1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09d35c34-11fa-3a5d-e063-6294a90ab172 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:84be93c5-1526-465e-ab0b-c6d10ba1521d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e4ed7ad2-cf58-4fdb-bc8c-d89f23b01210 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:575a31fb-04c5-4001-88a7-c33adbacc6a8 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdc5b438-6b6b-0cdd-e053-2a95a90a7f75 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c732db1-8321-82a4-e053-2991aa0aa8a0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50aa421f-1d73-4b43-8528-2617ef2507dc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb23383c-087a-4fb1-8917-edecd1ec4527 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34ff8a08-0177-451f-9dbc-e21582346196 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f8ba2c0-38e7-a536-e063-6294a90ace8d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b756c04-e7b8-4efe-815a-3f3e020727fb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6018b6e9-938d-4fc9-86d7-1fd1d7bfcc58 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bc7e2b4-e1a0-66e3-e063-6294a90a676a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15c0c7aa-8c54-4040-a1bf-2a7b421ad33f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1912d134-a909-5511-e063-6294a90aea29 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      138. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fbbc5b6-7aac-34e5-e054-00144ff88e88 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      139. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d536e88-62be-45bd-bd09-0efc53fe12b9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      140. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00b20a8c-debd-e930-e063-6394a90a7ed0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      141. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3aaa4808-7f2d-410c-9b6c-193549ec0845 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      142. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d64ca498-81c6-4e10-ba82-3a50ee47bcfc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      143. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00dbe051-a392-e2c6-e063-6394a90ab7f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      144. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59945ea1-8136-4014-acd9-cdfe6e11e8da (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      145. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c68d17e2-2311-8e17-e053-2995a90a565b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      146. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2286776-a7de-42dc-b745-d250e741eeb6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      147. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12645f19-fffc-8b08-e063-6394a90a5c55 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      148. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:90c7a982-6442-4241-a60b-b5dfab2abb71 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      149. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c51f56b-33c3-4611-bba8-876d9dde7aff (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      150. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cdde96c-9fc9-4698-872a-25c05318ecb5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      151. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c859f63a-09de-4eec-e053-2a95a90a312f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      152. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09d0e2fc-76a4-bb7d-e063-6394a90a4a7d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      153. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ab1b6f8-5d73-f97a-e063-6294a90a9fbf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      154. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37056cab-953e-43ba-9b4c-163a739a52f7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      155. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e530fd1e-06fd-0432-e053-2995a90adf5f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      156. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b06b11c-0546-4f6e-9509-ba612bbcb9fd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      157. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e04eea45-12ec-4d2b-e053-2a95a90a6b76 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      158. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c29cf8bd-2f63-ed4b-e053-2995a90ab6eb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      159. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc3cc6b6-c692-4986-8ff7-3a6cd8c85cb2 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      160. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:24653b10-bdf0-47c5-a1f4-dc25f3b86032 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      161. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e343fd12-1ca2-418a-b690-f3e8f567596d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      162. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4cc7965-2ba8-42e8-8c5c-b90145a6598a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      163. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29ca9548-23b0-4c50-82cb-4f0564d7e065 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      164. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2169957-9083-412c-a175-3071860c2b43 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.
      165. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dfe7288c-a477-4f32-a9ab-00cc981a1a57 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.

  2. Projected row 342

    Medicine slug
    cyclobenzaprine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    190
    Source count
    190
    Agreement rate
    0.868421
    Recorded readings

    1. 18 hours

      Numeric value
      18
      Unit
      hours
      Source records
      165

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 165 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4dcbdf8f-37ce-0f90-e063-6394a90ae83c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390151d4-5fcb-46e2-92e6-de184827f43d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ebaccfc-f57c-4547-ade0-6a6e204f5ea0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74af1727-e84f-4dad-82be-045e7d23beaf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db930d05-3f92-41f1-888c-301b2c4565e6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e505c31b-4618-4e4f-8da6-92030464004f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c054230-1978-44d2-9467-ed1994619113 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81917fa4-c79c-46e2-bfbb-507fc0d7ed1b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a397e88-d267-feed-e063-6294a90a7710 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f558863b-ea3f-4e4b-85e9-edb2573e7151 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d9e34cc-eee9-4147-abf8-c810a80e39d2 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51d85ea8-8317-4a76-a108-20383f118ad4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c3a3b4f-7b2b-3fe9-e063-6394a90aae47 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ac77323-7526-a129-e063-6394a90a641b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afca2a49-6424-7b6a-e053-2a95a90ad41e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1cb40f47-7fbb-4537-922d-04a08dd921c5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f32bceda-1d24-322d-e053-2995a90aae1b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:348c7ad4-b380-4b78-88f4-106b94079f52 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eb2b24b1-2851-440f-9075-b6a123a1fd5c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e6d82b-52fd-cca3-e063-6294a90a1104 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34e57aff-dc4b-4631-9d57-31020244835d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5023b8a5-c9df-84a4-e063-6294a90a9606 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a3a13c3-116c-4e9e-a7f3-7ad7c80486c3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4ae481f-9e47-470a-b4d1-5a33c0df8761 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:592871f6-0eb2-4624-9e10-bd8bf767c002 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07e3ec53-f1f2-4231-aec6-1772a146ba88 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e332763b-00c6-41bf-84ae-a07d9ef79697 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db49801d-9bde-5dd0-e053-2a95a90aee53 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30ca08c7-4ee3-2f37-e063-6294a90ae31a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f1b9c8a-8f75-4b84-af0c-739815937fd7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41838966-de0b-4855-83b8-2ff6c764ed1f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bddfe25-00ba-747f-e063-6394a90a9ce6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f89c8f6-7f3c-8396-e063-6294a90a643e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53688de9-2031-4d19-b422-4000285f7f47 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:08adc97f-feef-46fb-ac75-f015b4f3a43a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf5d4de9-79c3-4935-be69-89e98d7b54cc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a90171b-aef3-0691-e063-6294a90a6560 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3b5fc92-9186-6944-e053-2a95a90a1c9f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:794d350b-6c88-41d5-b68b-3e2c57ee2a4f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c86303a0-7c8b-415e-acac-1070b7d0d445 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8bdc725e-22e3-0f32-e053-2a95a90ae8a9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f321a03-ccfb-4c11-ac60-a461a5580c69 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa29e260-fb77-415a-a505-3230d30c8945 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3baeda95-d098-437a-b360-87a9c3f3fd9b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf3c4c2e-b089-4f83-9c6a-7ca9d9abd3ba (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:269bc278-963d-4830-816a-39bb4bf8c936 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3187074-6b55-44a3-b969-40a808eb034a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f708cf0f-8373-14a2-e053-6394a90ab3fe (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b834bd5-9ee6-42a4-819c-5c605fd18e1f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ee4feec-4590-fa7f-e063-6394a90a5550 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b09ca979-ab6b-441b-a66f-41ca32eae6cb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53bef1ab-55c0-cc52-e063-6394a90a12b3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43ce2c79-ec4a-5120-e063-6394a90af6e1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d6448bb1-9b8d-45f4-a14b-8328248e586e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dcef9b63-f998-4852-920d-c356623cea6a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae6de8d8-33c2-40bd-9dd3-782c879a9d8f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f14bc532-e30f-490f-b97b-d0dab9a2ba0c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3998083-e3db-4052-9b5b-19d7aaa4e658 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88bdee56-d6d9-4f14-be77-1e6898ba36f5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a6b2ad9-307a-4976-98b7-1b96e0408da7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a2d3cae-5c64-4986-9707-cc213b70b7ad (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59f31ca3-1b28-4768-bb29-520f06f4a9f5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7829a96a-3668-4d88-90e9-0ecbedb2bd7e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37c8c0d6-98c0-c1a5-e063-6394a90a7931 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6536b470-9a4e-4174-85b8-479f64cc3296 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc93038f-1202-47f3-a959-2877877cc869 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbe6ba88-0581-50ef-e053-6394a90ab086 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4e0f532-887b-40bb-80d6-5c4e5b1d64bf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06da53af-5b46-4e32-a64c-9677e27ae229 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf81da00-7c6d-4477-bb70-b3c2abea177a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e4e8bab3-c5e7-4d2b-9692-ee6c6799b120 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8bef97d4-1b92-4316-8733-7751d627230f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:571fbb2b-24e0-4de3-8cfa-c267fc397b6c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1adcdd8a-30f9-4a7b-853c-948a5589acab (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afca1267-4d8f-7453-e053-2995a90a865c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a58cf759-048b-6740-e053-2a95a90a8b43 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc61c9f5-b0ec-3ff8-e053-6394a90adeb7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bb92f6-ec8c-4636-8b07-8814417fe78e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34f4e63a-1259-0226-e063-6294a90a9fc4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64f6d1be-4067-a5c7-2343-4aed651a0cac (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dae3be94-a40c-5be1-e053-2a95a90a1484 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac8ae965-af50-41d3-8df5-ca6daf4bbd1c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae3a3f5c-fb64-4a43-be88-a2fc7c298ac1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:820dca15-5b7f-41e0-955f-73f942709264 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:508e310e-067a-4f95-869a-e1da49aabe94 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16ed7d7e-862f-db36-e063-6394a90a02a5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:106d9730-5938-8f27-e063-6294a90adc68 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2eb32c3-3da0-4938-9ed9-ea8420450fde (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afcab35f-4ab9-33a4-e053-2a95a90ad529 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b524d150-0a83-42d1-a884-b930e49760cd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85128989-bfa3-4b82-94c1-f90b14ccd2f9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:68db3c3b-8da1-4852-90b0-3172f842aa02 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be5201bc-e1f1-41af-be46-4a8fbb223b86 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:01e18825-1cf9-a98c-e063-6294a90ae0a4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:418e3974-f7dd-4f27-bee5-3c2fb0531c4c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbd38abb-02ae-1a36-e053-6294a90abe65 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05641925-7b10-4b30-b6e8-44b416a5e77e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96207b29-033b-46a3-961f-e5125288d50f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9161cb5e-63e5-41d7-9bde-66c7b7b7a2f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4383b26f-c39f-3d6a-e063-6294a90aba03 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4eaa675a-c24c-4043-8fdf-9d59e5e4f4d5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a2b5f25-a333-15f3-e054-00144ff8d46c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe81c68d-a579-4fe9-e053-6294a90a7bc0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55683c5c-0f86-9a26-e063-6294a90a8e8c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df902d94-9d2b-4139-aebb-3eb6b8b8cd54 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0280b504-4a42-44f3-8a1a-34a20eac054a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8dec4e2-3151-4a79-b194-a11a57ada0b6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:014dd648-5b84-4d1d-80fc-a467e2d741ef (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15aad4af-5c05-be36-e063-6294a90a9bb3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4923ac1f-d463-465b-9e99-7312aef87861 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ceb56ab8-4a76-6dee-e053-2995a90aab30 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1154688c-1383-442b-a3a5-ec01e038795c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:751f0d33-ceff-40b0-9329-9125f176e06a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c66b5ed-f773-0779-e053-2995a90ad1f1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:193744c8-ff8e-4f65-aec1-1c13f471ac82 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a695685-cfec-464e-840c-32e3b7a68bd3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afcad582-ab59-4f70-e053-2a95a90a04e4 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b062cb80-79a9-c5d8-e053-2a95a90aecfc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59b428fa-5013-4b2b-872f-16ba4a9d4f5d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a264ab9f-cc12-325f-e053-2a95a90a53d9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eb908b77-741c-473a-b2e9-4f82167c3088 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:47d22c6d-49fb-f97c-e063-6294a90a6ba1 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09d35c34-11fa-3a5d-e063-6294a90ab172 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:84be93c5-1526-465e-ab0b-c6d10ba1521d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e4ed7ad2-cf58-4fdb-bc8c-d89f23b01210 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:575a31fb-04c5-4001-88a7-c33adbacc6a8 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdc5b438-6b6b-0cdd-e053-2a95a90a7f75 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c732db1-8321-82a4-e053-2991aa0aa8a0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50aa421f-1d73-4b43-8528-2617ef2507dc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb23383c-087a-4fb1-8917-edecd1ec4527 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34ff8a08-0177-451f-9dbc-e21582346196 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f8ba2c0-38e7-a536-e063-6294a90ace8d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b756c04-e7b8-4efe-815a-3f3e020727fb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6018b6e9-938d-4fc9-86d7-1fd1d7bfcc58 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bc7e2b4-e1a0-66e3-e063-6294a90a676a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15c0c7aa-8c54-4040-a1bf-2a7b421ad33f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1912d134-a909-5511-e063-6294a90aea29 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      138. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fbbc5b6-7aac-34e5-e054-00144ff88e88 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      139. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d536e88-62be-45bd-bd09-0efc53fe12b9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      140. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00b20a8c-debd-e930-e063-6394a90a7ed0 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      141. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3aaa4808-7f2d-410c-9b6c-193549ec0845 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      142. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d64ca498-81c6-4e10-ba82-3a50ee47bcfc (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      143. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00dbe051-a392-e2c6-e063-6394a90ab7f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      144. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59945ea1-8136-4014-acd9-cdfe6e11e8da (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      145. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c68d17e2-2311-8e17-e053-2995a90a565b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      146. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2286776-a7de-42dc-b745-d250e741eeb6 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      147. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12645f19-fffc-8b08-e063-6394a90a5c55 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      148. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:90c7a982-6442-4241-a60b-b5dfab2abb71 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      149. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c51f56b-33c3-4611-bba8-876d9dde7aff (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      150. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cdde96c-9fc9-4698-872a-25c05318ecb5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      151. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c859f63a-09de-4eec-e053-2a95a90a312f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      152. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09d0e2fc-76a4-bb7d-e063-6394a90a4a7d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      153. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ab1b6f8-5d73-f97a-e063-6294a90a9fbf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      154. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37056cab-953e-43ba-9b4c-163a739a52f7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      155. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e530fd1e-06fd-0432-e053-2995a90adf5f (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      156. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b06b11c-0546-4f6e-9509-ba612bbcb9fd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      157. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e04eea45-12ec-4d2b-e053-2a95a90a6b76 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min.
      158. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c29cf8bd-2f63-ed4b-e053-2995a90ab6eb (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      159. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc3cc6b6-c692-4986-8ff7-3a6cd8c85cb2 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      160. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:24653b10-bdf0-47c5-a1f4-dc25f3b86032 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      161. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e343fd12-1ca2-418a-b690-f3e8f567596d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      162. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4cc7965-2ba8-42e8-8c5c-b90145a6598a (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      163. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29ca9548-23b0-4c50-82cb-4f0564d7e065 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min.
      164. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2169957-9083-412c-a175-3071860c2b43 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.
      165. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dfe7288c-a477-4f32-a9ab-00cc981a1a57 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min.

    2. 32 hours

      Numeric value
      32
      Unit
      hours
      Source records
      24

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 24 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:259fb05a-4f45-9c8e-e063-6294a90a4484 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2998c9e6-2f60-ef35-e063-6394a90a7bc7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dd2bde1-f06d-493a-91c7-22b28a5e1699 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4457b8c-fff8-4c19-8d5a-a667161e5446 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8112916-28ae-452c-8ec8-a4972e5f549b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3902123b-1365-ac3c-0934-afff9eeeb1bd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of AMRIX.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:550d3e5a-c95f-4094-a500-1a02ea35a18d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a512d34c-8164-0c04-e053-2995a90a1942 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a116427-c427-c3bc-e063-6294a90ac539 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:48c33e51-db07-af68-e063-6294a90a897e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfdd9460-5dfa-4588-8f4f-9d227c1717d5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3175d24d-e8a0-4f14-bed9-a60ad59ac7e7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba659e1a-0091-45f6-b418-f4f36c9a2c79 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fada6577-bcb8-422c-be37-08562919ebc9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2169667d-4f4b-472d-929b-8a0bcbddbe9c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30e61110-5bc8-4134-8456-538558479735 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd546a0e-e5be-4232-8ad8-fcd7d5f9a903 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1af467cb-7b21-4084-bb54-4634e928b167 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ffd82a69-a64c-4399-8f5d-bddc70cdc3cf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a8c9479-b3ab-453a-bd8a-deaf38000742 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96b650d8-4ad5-42af-aa8c-aa0ac25abfb5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca74d27a-f7c6-462d-a913-1cfa061bd8f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8360da5-f1d3-1d89-e053-6294a90ad31c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8 to 37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f64ceb-ea5c-4d7c-a0c1-3f6a64847290 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Cyclobenzaprine has an elimination half-life of 32 hours (range 8-37 hours; n=18); plasma clearance is 0.7 L/min following single-dose administration of cyclobenzaprine hydrochloride extended-release capsules.

    3. 36 hours

      Numeric value
      36
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6fa59588-ce9b-48cf-8c5f-725a448f8571 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Elimination TONMYA has a single dose elimination half-life of approximately 36 hours (range 28-59 hours; n=16).

  3. Projected row 343

    Medicine slug
    cyclobenzaprine
    Compared field
    tMax
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    190
    Source count
    25
    Agreement rate
    0.96
    Recorded readings

    1. 7 to 8 hours

      Numeric value
      7
      Unit
      hours
      Source records
      24

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 24 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:259fb05a-4f45-9c8e-e063-6294a90a4484 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2998c9e6-2f60-ef35-e063-6394a90a7bc7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dd2bde1-f06d-493a-91c7-22b28a5e1699 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4457b8c-fff8-4c19-8d5a-a667161e5446 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8112916-28ae-452c-8ec8-a4972e5f549b (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3902123b-1365-ac3c-0934-afff9eeeb1bd (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of AMRIX.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:550d3e5a-c95f-4094-a500-1a02ea35a18d (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a512d34c-8164-0c04-e053-2995a90a1942 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (Tmax) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a116427-c427-c3bc-e063-6294a90ac539 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:48c33e51-db07-af68-e063-6294a90a897e (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfdd9460-5dfa-4588-8f4f-9d227c1717d5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3175d24d-e8a0-4f14-bed9-a60ad59ac7e7 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba659e1a-0091-45f6-b418-f4f36c9a2c79 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fada6577-bcb8-422c-be37-08562919ebc9 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2169667d-4f4b-472d-929b-8a0bcbddbe9c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30e61110-5bc8-4134-8456-538558479735 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd546a0e-e5be-4232-8ad8-fcd7d5f9a903 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1af467cb-7b21-4084-bb54-4634e928b167 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ffd82a69-a64c-4399-8f5d-bddc70cdc3cf (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a8c9479-b3ab-453a-bd8a-deaf38000742 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96b650d8-4ad5-42af-aa8c-aa0ac25abfb5 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca74d27a-f7c6-462d-a913-1cfa061bd8f3 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8360da5-f1d3-1d89-e053-6294a90ad31c (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (Tmax) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f64ceb-ea5c-4d7c-a0c1-3f6a64847290 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        The time to peak plasma cyclobenzaprine concentration (T max ) was 7 to 8 hours for both doses of cyclobenzaprine hydrochloride extended-release capsules.

    2. 4.3 hours

      Numeric value
      4.3
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6fa59588-ce9b-48cf-8c5f-725a448f8571 (opens source in a new tab)

        Cyclobenzaprine label

        Version not recorded · Effective date not recorded

        Absorption The median time to peak plasma cyclobenzaprine concentration (T max ) was approximately 4.3 hours for the 2.8 mg and 5.6 mg once daily TONMYA dosages.

  4. Projected row 344

    Medicine slug
    cyclophosphamide
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    31
    Source count
    31
    Agreement rate
    0.967742
    Recorded readings

    1. 3 to 12 hours

      Numeric value
      3
      Unit
      hours
      Source records
      30

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 30 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1de02105-9c5b-4d11-bddf-bf8450d88b78 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e699cf7-860e-4c03-9760-0c24d56df2de (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t ½ ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7e97b99-83db-42d0-8521-b87fe6467a67 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:591d9955-3d9c-4cdc-a308-2f1288376b9f (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cef038cc-efab-46d9-99c2-95bb11d6c9bc (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:02e64046-687d-449e-e063-6294a90a6c32 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8135b917-882f-4b4c-99b7-fa8ea54af4bf (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t ½ ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76f057be-e3da-0a89-e053-2a91aa0a8438 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d3396d8-4c03-4a28-890a-d87c6c53a74e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:520bfe39-dfd5-4a20-9a37-80078afded0d (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t1/2) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h .
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0e1cb955-99c8-4fe5-89d1-399c8e52174e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5818647-d840-e9d7-c7b8-6541b485e44e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2873b99a-830d-0a7b-e063-6394a90a4de7 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t ½ ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0afd2cc7-09e6-481a-afea-9d2e3742da46 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34dbffee-80e0-49c3-90e8-95713a0b7fbe (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The cyclophosphamide elimination half-life ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h following IV administration.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6f593585-e0dd-48bc-bd2b-c6c787e0b98c (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The cyclophosphamide elimination half-life ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h following IV administration.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:329b5a3a-c7b9-4b11-abf0-009719cdfb79 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t ½ ) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c961a1ac-6705-4756-9abc-9d84a6fcb5c8 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ad8ea65-4c98-487a-9c8d-df778765ec5e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and the clearance (CL) ranges from 4 to 5.6 L/h.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c1eb470-0bba-457d-94e3-b9508f0d398a (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The cyclophosphamide elimination half-life ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h following IV administration.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8057d1a-e8af-42ab-9da2-b545730b2655 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t ½ ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97ab446f-5017-4180-ae65-0a355289b0ed (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:988d2f71-1dc7-45b5-b2df-187e68224973 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31986d36-a1bf-4903-93a4-ce7386241ba1 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf2f4b95-0327-499a-a5a3-51b1bdef68c5 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7d6447e3-22c9-48d9-87c0-d0b576d7ea9e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t ½ ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0e9e22fa-178a-42fc-9f82-c303db3b245a (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Following IV administration, elimination half-life (t 1/2 ) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8627c83f-c057-495d-9f78-8b67bda97b3e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Elimination The elimination half-life (t½) of cyclophosphamide ranges from 3 to 12 hours, and clearance (CL) ranges from 4 to 5.6 L/h.

    2. 3.3 hours

      Numeric value
      3.3
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:769ded74-6186-40a8-8e44-ceff67287451 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        The elimination half-life (t 1/2 ) was 3.3 hours in patients during hemodialysis, a 49% reduction of the 6.5 hours to t 1/2 reported in uremic patients.

  5. Projected row 345

    Medicine slug
    cyclophosphamide
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    31
    Source count
    31
    Agreement rate
    1
    Recorded readings

    1. 30 to 50 L

      Numeric value
      30
      Unit
      L
      Source records
      31

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 31 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1de02105-9c5b-4d11-bddf-bf8450d88b78 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e699cf7-860e-4c03-9760-0c24d56df2de (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7e97b99-83db-42d0-8521-b87fe6467a67 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:591d9955-3d9c-4cdc-a308-2f1288376b9f (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cef038cc-efab-46d9-99c2-95bb11d6c9bc (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:769ded74-6186-40a8-8e44-ceff67287451 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:02e64046-687d-449e-e063-6294a90a6c32 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8135b917-882f-4b4c-99b7-fa8ea54af4bf (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76f057be-e3da-0a89-e053-2a91aa0a8438 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d3396d8-4c03-4a28-890a-d87c6c53a74e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:520bfe39-dfd5-4a20-9a37-80078afded0d (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0e1cb955-99c8-4fe5-89d1-399c8e52174e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5818647-d840-e9d7-c7b8-6541b485e44e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2873b99a-830d-0a7b-e063-6394a90a4de7 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0afd2cc7-09e6-481a-afea-9d2e3742da46 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:34dbffee-80e0-49c3-90e8-95713a0b7fbe (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution Cyclophosphamide volume of distribution approximates total body water (30 to 50 L).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6f593585-e0dd-48bc-bd2b-c6c787e0b98c (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution Cyclophosphamide volume of distribution approximates total body water (30 to 50 L).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:329b5a3a-c7b9-4b11-abf0-009719cdfb79 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c961a1ac-6705-4756-9abc-9d84a6fcb5c8 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ad8ea65-4c98-487a-9c8d-df778765ec5e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c1eb470-0bba-457d-94e3-b9508f0d398a (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution Cyclophosphamide volume of distribution approximates total body water (30 to 50 L).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8057d1a-e8af-42ab-9da2-b545730b2655 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97ab446f-5017-4180-ae65-0a355289b0ed (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:988d2f71-1dc7-45b5-b2df-187e68224973 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31986d36-a1bf-4903-93a4-ce7386241ba1 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf2f4b95-0327-499a-a5a3-51b1bdef68c5 (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7d6447e3-22c9-48d9-87c0-d0b576d7ea9e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0e9e22fa-178a-42fc-9f82-c303db3b245a (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Volume of distribution approximates total body water (30 to 50 L).
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8627c83f-c057-495d-9f78-8b67bda97b3e (opens source in a new tab)

        Cyclophosphamide label

        Version not recorded · Effective date not recorded

        Distribution The volume of distribution of cyclophosphamide is 30 to 50 L.

  6. Projected row 346

    Medicine slug
    cyclosporine
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    24
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 30%

      Numeric value
      30
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e5926a7-1de0-4b54-a5c0-286b6200ff82 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Compared to an intravenous infusion, the absolute bioavailability of soft gelatin capsules is approximately 30%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfca7088-fe93-abb9-3ec3-e6f5710a69c6 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Compared to an intravenous infusion, the absolute bioavailability of soft gelatin capsules is approximately 30%.

  7. Projected row 347

    Medicine slug
    cyclosporine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    24
    Source count
    10
    Agreement rate
    0.7
    Recorded readings

    1. 8.4 hours

      Numeric value
      8.4
      Unit
      hours
      Source records
      7

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 7 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2de1e8b1-625f-43ce-a1d5-d543be208b11 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5baaf78c-90f6-abcf-52c8-814490f3cf9f (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1952d4c7-a40e-4924-b669-c41400774cb9 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3dc2a50-1084-4190-a6f3-37034a04db86 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64ec430a-e930-145c-e766-13fb49b64644 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e896cbfe-4745-4088-82a3-8dc10b75c41f (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range 5 to 18 hours).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94461af3-11f1-4670-95d4-2965b9538ae3 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is generally biphasic, with a terminal half-life of approximately 8.4 hours (range, 5 to 18 hours).

    2. 19 hours

      Numeric value
      19
      Unit
      hours
      Source records
      3

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 3 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e5926a7-1de0-4b54-a5c0-286b6200ff82 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is biphasic with a terminal half-life of approximately 19 hours (range, 10 to 27 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8e29b54-e4ab-4bb9-ab6c-e4414a3f025b (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is biphasic with a terminal half-life of approximately 19 hours (range, 10 to 27 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfca7088-fe93-abb9-3ec3-e6f5710a69c6 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The disposition of cyclosporine from blood is biphasic with a terminal half-life of approximately 19 hours (range, 10 to 27 hours).

  8. Projected row 348

    Medicine slug
    cyclosporine
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    24
    Source count
    3
    Agreement rate
    1
    Recorded readings

    1. 3.5 hours

      Numeric value
      3.5
      Unit
      hours
      Source records
      3

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 3 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e5926a7-1de0-4b54-a5c0-286b6200ff82 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Peak concentrations (C max ) in blood and plasma are achieved at about 3.5 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8e29b54-e4ab-4bb9-ab6c-e4414a3f025b (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Peak concentrations (C max ) in blood and plasma are achieved at about 3.5 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfca7088-fe93-abb9-3ec3-e6f5710a69c6 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Peak concentrations (C max ) in blood and plasma are achieved at about 3.5 hours.

  9. Projected row 349

    Medicine slug
    cyclosporine
    Compared field
    volumeOfDistribution
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    24
    Source count
    10
    Agreement rate
    0.7
    Recorded readings

    1. 3 to 5 L/kg

      Numeric value
      3
      Unit
      L/kg
      Source records
      7

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 7 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2de1e8b1-625f-43ce-a1d5-d543be208b11 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5baaf78c-90f6-abcf-52c8-814490f3cf9f (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1952d4c7-a40e-4924-b669-c41400774cb9 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3dc2a50-1084-4190-a6f3-37034a04db86 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64ec430a-e930-145c-e766-13fb49b64644 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e896cbfe-4745-4088-82a3-8dc10b75c41f (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94461af3-11f1-4670-95d4-2965b9538ae3 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution during intravenous dosing has been reported as 3 to 5 L/kg in solid organ transplant recipients.

    2. 3.49 L/kg

      Numeric value
      3.49
      Unit
      L/kg
      Source records
      3

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 3 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e5926a7-1de0-4b54-a5c0-286b6200ff82 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        disease (creatinine clearance < 5 mL/min), an intravenous infusion of 3.5 mg/kg of cyclosporine over 4 hours administered at the end of a hemodialysis session resulted in a mean volume of distribution (Vdss) of 3.49 L/kg and systemic clearance (CL) of 0.369 L/hr/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8e29b54-e4ab-4bb9-ab6c-e4414a3f025b (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        Specific Populations Renal Impairment In a study performed in 4 subjects with end-stage renal disease (creatinine clearance <5 mL/min), an intravenous infusion of 3.5 mg/kg of cyclosporine over 4 hours administered at the end of a hemodialysis session resulted in a mean volume of distribution (Vdss) of 3.49 L/kg and systemic clearance (CL) of 0.369 L/hr/kg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfca7088-fe93-abb9-3ec3-e6f5710a69c6 (opens source in a new tab)

        Cyclosporine label

        Version not recorded · Effective date not recorded

        disease (creatinine clearance < 5 mL/min), an intravenous infusion of 3.5 mg/kg of cyclosporine over 4 hours administered at the end of a hemodialysis session resulted in a mean volume of distribution (Vdss) of 3.49 L/kg and systemic clearance (CL) of 0.369 L/hr/kg.

  10. Projected row 350

    Medicine slug
    cysteamine
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    4
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 52%

      Numeric value
      52
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3a3ec28-f746-463a-bb92-3bc8826db09e (opens source in a new tab)

        Cysteamine label

        Version not recorded · Effective date not recorded

        Distribution Cysteamine was moderately bound to human plasma proteins, predominantly to albumin, with mean protein binding of about 52%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f495b76d-96c6-48e5-8fa3-30a4336628eb (opens source in a new tab)

        Cysteamine label

        Version not recorded · Effective date not recorded

        Cysteamine was moderately bound to human plasma proteins, predominantly to albumin, with mean protein binding of about 52%.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=340

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy